SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '1v0f'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1FDU_A_ESTA351_1 (17-BETA-HYDROXYSTERO ID DEHYDROGENASE)	1v0f	ENDO-ALPHA-SIALIDASE (Enterobacteria phage K1F)	5 / 12	VAL A 551 GLY A 552 LEU A 593 LEU A 620 SER A 619	VAL A 551 ( 0.6A) GLY A 552 ( 0.0A) LEU A 593 ( 0.5A) LEU A 620 ( 0.6A) SER A 619 ( 0.0A)	1.04A	1fduA-1v0fA: undetectable	1fduA-1v0fA: 19.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1KQB_D_BEZD523_0 (OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE)	1v0f	ENDO-ALPHA-SIALIDASE (Enterobacteria phage K1F)	4 / 6	PHE A 718 GLU A 721 GLY A 720 SER A 700	PHE A 718 ( 1.3A) GLU A 721 ( 0.6A) GLY A 720 ( 0.0A) SER A 700 ( 0.0A)	1.16A	1kqbC-1v0fA: undetectable 1kqbD-1v0fA: undetectable	1kqbC-1v0fA: 14.61 1kqbD-1v0fA: 14.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1MAA_B_DMEB996_1 (ACETYLCHOLINESTERASE)	1v0f	ENDO-ALPHA-SIALIDASE (Enterobacteria phage K1F)	4 / 6	GLU A 309 ILE A 714 TYR A 713 GLY A 755	GLU A 309 ( 0.6A) ILE A 714 ( 0.7A) TYR A 713 ( 1.3A) GLY A 755 ( 0.0A)	1.05A	1maaB-1v0fA: undetectable 1maaD-1v0fA: undetectable	1maaB-1v0fA: 22.78 1maaD-1v0fA: 22.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1W5U_B_DVAB8_0 (GRAMICIDIN D)	1v0f	ENDO-ALPHA-SIALIDASE (Enterobacteria phage K1F)	3 / 3	VAL A 704 VAL A 702 TRP A 328	VAL A 704 ( 0.6A) VAL A 702 ( 0.5A) TRP A 328 ( 0.5A)	0.95A	1w5uA-1v0fA: undetectable 1w5uB-1v0fA: undetectable	1w5uA-1v0fA: 3.41 1w5uB-1v0fA: 3.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2A3C_A_PNXA1435_1 (CHITINASE)	1v0f	ENDO-ALPHA-SIALIDASE (Enterobacteria phage K1F)	4 / 6	TYR A 716 GLY A 597 SER A 605 ARG A 596	TYR A 716 ( 1.3A) GLY A 597 ( 0.0A) SER A 605 ( 0.0A) ARG A 596 ( 0.6A)	1.24A	2a3cA-1v0fA: undetectable	2a3cA-1v0fA: 21.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2A3C_B_PNXB2434_1 (CHITINASE)	1v0f	ENDO-ALPHA-SIALIDASE (Enterobacteria phage K1F)	4 / 6	TYR A 716 GLY A 597 SER A 605 ARG A 596	TYR A 716 ( 1.3A) GLY A 597 ( 0.0A) SER A 605 ( 0.0A) ARG A 596 ( 0.6A)	1.22A	2a3cB-1v0fA: undetectable	2a3cB-1v0fA: 21.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2IJ7_D_TPFD2473_1 (CYTOCHROME P450 121)	1v0f	ENDO-ALPHA-SIALIDASE (Enterobacteria phage K1F)	5 / 10	THR A 465 VAL A 464 ASN A 495 THR A 434 ALA A 436	THR A 465 ( 0.9A) VAL A 464 ( 0.6A) ASN A 495 ( 0.6A) THR A 434 ( 0.9A) ALA A 436 ( 0.0A)	1.32A	2ij7D-1v0fA: 0.0	2ij7D-1v0fA: 20.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2IZQ_C_DVAC8_0 (GRAMICIDIN D)	1v0f	ENDO-ALPHA-SIALIDASE (Enterobacteria phage K1F)	3 / 3	VAL A 702 TRP A 328 VAL A 704	VAL A 702 ( 0.5A) TRP A 328 ( 0.5A) VAL A 704 ( 0.6A)	0.98A	2izqC-1v0fA: undetectable 2izqD-1v0fA: undetectable	2izqC-1v0fA: 3.41 2izqD-1v0fA: 3.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2VOU_B_ACTB1391_0 (2,6-DIHYDROXYPYRIDIN E HYDROXYLASE)	1v0f	ENDO-ALPHA-SIALIDASE (Enterobacteria phage K1F)	3 / 3	PRO A 632 GLY A 705 TYR A 716	PRO A 632 ( 1.1A) GLY A 705 ( 0.0A) TYR A 716 ( 1.3A)	0.65A	2vouB-1v0fA: undetectable	2vouB-1v0fA: 22.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2VOU_C_ACTC1391_0 (2,6-DIHYDROXYPYRIDIN E HYDROXYLASE)	1v0f	ENDO-ALPHA-SIALIDASE (Enterobacteria phage K1F)	3 / 3	PRO A 632 GLY A 705 TYR A 716	PRO A 632 ( 1.1A) GLY A 705 ( 0.0A) TYR A 716 ( 1.3A)	0.66A	2vouC-1v0fA: undetectable	2vouC-1v0fA: 22.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2XRZ_B_ACTB1463_0 (DEOXYRIBODIPYRIMIDIN E PHOTOLYASE)	1v0f	ENDO-ALPHA-SIALIDASE (Enterobacteria phage K1F)	4 / 7	VAL A 464 ILE A 433 ALA A 442 GLY A 466	VAL A 464 ( 0.6A) ILE A 433 ( 0.7A) ALA A 442 ( 0.0A) GLY A 466 ( 0.0A)	0.75A	2xrzB-1v0fA: undetectable	2xrzB-1v0fA: 20.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3AI8_B_HNQB255_1 (CATHEPSIN B)	1v0f	ENDO-ALPHA-SIALIDASE (Enterobacteria phage K1F)	4 / 6	GLN A 330 GLY A 705 HIS A 350 TRP A 328	GLN A 330 ( 0.6A) GLY A 705 ( 0.0A) HIS A 350 ( 1.0A) TRP A 328 ( 0.5A)	1.46A	3ai8B-1v0fA: undetectable	3ai8B-1v0fA: 17.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4KHP_A_PARA1606_1 (16S RIBOSOMAL RNA 30S RIBOSOMAL PROTEIN S9 30S RIBOSOMAL PROTEIN S10)	1v0f	ENDO-ALPHA-SIALIDASE (Enterobacteria phage K1F)	3 / 3	TYR A 382 ARG A 354 SER A 353	TYR A 382 ( 1.3A) ARG A 354 ( 0.6A) SER A 353 ( 0.0A)	1.11A	4khpI-1v0fA: undetectable 4khpJ-1v0fA: undetectable	4khpI-1v0fA: 11.48 4khpJ-1v0fA: 9.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4KOS_A_4KOA201_1 (UNCHARACTERIZED PROTEIN)	1v0f	ENDO-ALPHA-SIALIDASE (Enterobacteria phage K1F)	5 / 12	PRO A 372 TYR A 324 GLY A 346 ASN A 326 MET A 345	PRO A 372 ( 1.1A) TYR A 324 ( 1.3A) GLY A 346 ( 0.0A) ASN A 326 ( 0.6A) MET A 345 ( 0.0A)	1.34A	4kosA-1v0fA: undetectable	4kosA-1v0fA: 12.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4KOV_A_KOVA204_1 (UNCHARACTERIZED PROTEIN)	1v0f	ENDO-ALPHA-SIALIDASE (Enterobacteria phage K1F)	5 / 12	PRO A 372 TYR A 324 GLY A 346 ASN A 326 MET A 345	PRO A 372 ( 1.1A) TYR A 324 ( 1.3A) GLY A 346 ( 0.0A) ASN A 326 ( 0.6A) MET A 345 ( 0.0A)	1.36A	4kovA-1v0fA: undetectable	4kovA-1v0fA: 12.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4KOW_A_CFXA204_1 (UNCHARACTERIZED PROTEIN)	1v0f	ENDO-ALPHA-SIALIDASE (Enterobacteria phage K1F)	5 / 12	PRO A 372 TYR A 324 GLY A 346 ASN A 326 MET A 345	PRO A 372 ( 1.1A) TYR A 324 ( 1.3A) GLY A 346 ( 0.0A) ASN A 326 ( 0.6A) MET A 345 ( 0.0A)	1.34A	4kowA-1v0fA: 0.0	4kowA-1v0fA: 12.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4KOX_A_CLSA205_1 (UNCHARACTERIZED PROTEIN)	1v0f	ENDO-ALPHA-SIALIDASE (Enterobacteria phage K1F)	5 / 11	PRO A 372 TYR A 324 GLY A 346 ASN A 326 MET A 345	PRO A 372 ( 1.1A) TYR A 324 ( 1.3A) GLY A 346 ( 0.0A) ASN A 326 ( 0.6A) MET A 345 ( 0.0A)	1.38A	4koxA-1v0fA: 0.0	4koxA-1v0fA: 12.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4KOY_A_CSCA214_1 (UNCHARACTERIZED PROTEIN)	1v0f	ENDO-ALPHA-SIALIDASE (Enterobacteria phage K1F)	5 / 11	PRO A 372 TYR A 324 GLY A 346 ASN A 326 MET A 345	PRO A 372 ( 1.1A) TYR A 324 ( 1.3A) GLY A 346 ( 0.0A) ASN A 326 ( 0.6A) MET A 345 ( 0.0A)	1.37A	4koyA-1v0fA: undetectable	4koyA-1v0fA: 12.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4X5I_A_FOLA201_1 (DIHYDROFOLATE REDUCTASE)	1v0f	ENDO-ALPHA-SIALIDASE (Enterobacteria phage K1F)	3 / 3	ASP A 731 ARG A 349 ARG A 354	ASP A 731 ( 0.6A) ARG A 349 ( 0.6A) ARG A 354 ( 0.6A)	0.96A	4x5iA-1v0fA: 0.0	4x5iA-1v0fA: 15.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4YMG_B_SAMB1001_1 (PUTATIVE SAM-DEPENDENT O-METHYLTRANFERASE)	1v0f	ENDO-ALPHA-SIALIDASE (Enterobacteria phage K1F)	3 / 3	SER A 605 GLU A 651 GLU A 721	SER A 605 ( 0.0A) GLU A 651 ( 0.6A) GLU A 721 ( 0.6A)	0.87A	4ymgB-1v0fA: undetectable	4ymgB-1v0fA: 17.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5CZY_A_SAMA603_0 (LEGIONELLA EFFECTOR LEGAS4)	1v0f	ENDO-ALPHA-SIALIDASE (Enterobacteria phage K1F)	5 / 12	LEU A 640 ARG A 672 TYR A 670 TYR A 592 LEU A 607	LEU A 640 ( 0.5A) ARG A 672 ( 0.6A) TYR A 670 ( 1.3A) TYR A 592 ( 1.3A) LEU A 607 ( 0.5A)	1.33A	5czyA-1v0fA: undetectable	5czyA-1v0fA: 20.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ECO_A_LEUA602_0 (JASMONIC ACID-AMIDO SYNTHETASE JAR1)	1v0f	ENDO-ALPHA-SIALIDASE (Enterobacteria phage K1F)	4 / 6	THR A 483 ALA A 474 THR A 475 VAL A 453	THR A 483 ( 0.9A) ALA A 474 ( 0.0A) THR A 475 ( 0.9A) VAL A 453 ( 0.6A)	0.74A	5ecoA-1v0fA: undetectable	5ecoA-1v0fA: 23.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5N8J_E_DVAE7_0 (GLY-DTY-GLY-DLE-DAL- DSG-DVA-DAS-DGL-DSN- DSN-GLY STREPTAVIDIN)	1v0f	ENDO-ALPHA-SIALIDASE (Enterobacteria phage K1F)	3 / 3	TYR A 592 SER A 610 TRP A 678	TYR A 592 ( 1.3A) SER A 610 ( 0.0A) TRP A 678 ( 0.5A)	0.98A	5n8jB-1v0fA: undetectable	5n8jB-1v0fA: 13.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5N8J_O_DVAO7_0 (GLY-DTY-GLY-DLE-DAL- DSG-DVA-DAS-DGL-DSN- DSN-GLY STREPTAVIDIN)	1v0f	ENDO-ALPHA-SIALIDASE (Enterobacteria phage K1F)	3 / 3	TYR A 592 SER A 610 TRP A 678	TYR A 592 ( 1.3A) SER A 610 ( 0.0A) TRP A 678 ( 0.5A)	0.93A	5n8jA-1v0fA: undetectable	5n8jA-1v0fA: 13.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5N8J_P_DVAP5_0 (GLY-DTY-GLY-DLE-DAL- DSG-DVA-DAS-DGL-DSN- DSN-GLY STREPTAVIDIN)	1v0f	ENDO-ALPHA-SIALIDASE (Enterobacteria phage K1F)	3 / 3	TYR A 592 SER A 610 TRP A 678	TYR A 592 ( 1.3A) SER A 610 ( 0.0A) TRP A 678 ( 0.5A)	0.90A	5n8jD-1v0fA: undetectable	5n8jD-1v0fA: 13.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6BRD_C_RFPC502_1 (RIFAMPIN MONOOXYGENASE)	1v0f	ENDO-ALPHA-SIALIDASE (Enterobacteria phage K1F)	5 / 12	VAL A 473 VAL A 457 GLY A 431 THR A 465 GLY A 466	VAL A 473 ( 0.6A) VAL A 457 ( 0.6A) GLY A 431 ( 0.0A) THR A 465 ( 0.9A) GLY A 466 ( 0.0A)	1.08A	6brdC-1v0fA: undetectable	6brdC-1v0fA: 7.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6DWJ_B_GLYB710_0 (DEOXYNUCLEOSIDE TRIPHOSPHATE TRIPHOSPHOHYDROLASE SAMHD1)	1v0f	ENDO-ALPHA-SIALIDASE (Enterobacteria phage K1F)	4 / 5	ARG A 784 GLY A 782 ASN A 781 ASP A 779	ARG A 784 ( 0.6A) GLY A 782 ( 0.0A) ASN A 781 ( 0.6A) ASP A 779 ( 0.6A)	1.38A	6dwjB-1v0fA: undetectable 6dwjD-1v0fA: undetectable	6dwjB-1v0fA: 21.34 6dwjD-1v0fA: 21.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6GH9_A_MIXA1003_0 (UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 15)	1v0f	ENDO-ALPHA-SIALIDASE (Enterobacteria phage K1F)	4 / 5	ASN A 732 TYR A 325 GLY A 346 HIS A 743	ASN A 732 ( 0.6A) TYR A 325 ( 1.3A) GLY A 346 ( 0.0A) HIS A 743 ( 1.0A)	1.29A	6gh9A-1v0fA: undetectable	6gh9A-1v0fA: 10.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6HD4_A_STIA604_1 (TYROSINE-PROTEIN KINASE ABL1)	1v0f	ENDO-ALPHA-SIALIDASE (Enterobacteria phage K1F)	4 / 5	TYR A 278 VAL A 267 PHE A 311 GLY A 275	TYR A 278 ( 1.3A) VAL A 267 ( 0.5A) PHE A 311 ( 1.3A) GLY A 275 ( 0.0A)	1.32A	6hd4A-1v0fA: undetectable	6hd4A-1v0fA: 8.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6HIS_B_TKTB508_0 (5-HYDROXYTRYPTAMINE RECEPTOR 3A)	1v0f	ENDO-ALPHA-SIALIDASE (Enterobacteria phage K1F)	4 / 8	ASP A 420 ARG A 398 ARG A 513 ASN A 534	ASP A 420 ( 0.6A) ARG A 398 ( 0.6A) ARG A 513 ( 0.6A) ASN A 534 ( 0.6A)	1.03A	6hisB-1v0fA: undetectable 6hisC-1v0fA: undetectable	6hisB-1v0fA: 8.39 6hisC-1v0fA: 8.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6HIS_C_TKTC508_0 (5-HYDROXYTRYPTAMINE RECEPTOR 3A)	1v0f	ENDO-ALPHA-SIALIDASE (Enterobacteria phage K1F)	4 / 8	ASP A 420 ARG A 398 ARG A 513 ASN A 534	ASP A 420 ( 0.6A) ARG A 398 ( 0.6A) ARG A 513 ( 0.6A) ASN A 534 ( 0.6A)	1.01A	6hisC-1v0fA: undetectable 6hisD-1v0fA: undetectable	6hisC-1v0fA: 8.39 6hisD-1v0fA: 8.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6HIS_E_TKTE501_0 (5-HYDROXYTRYPTAMINE RECEPTOR 3A)	1v0f	ENDO-ALPHA-SIALIDASE (Enterobacteria phage K1F)	4 / 8	ASN A 534 ASP A 420 ARG A 398 ARG A 513	ASN A 534 ( 0.6A) ASP A 420 ( 0.6A) ARG A 398 ( 0.6A) ARG A 513 ( 0.6A)	1.01A	6hisA-1v0fA: undetectable 6hisE-1v0fA: undetectable	6hisA-1v0fA: 8.39 6hisE-1v0fA: 8.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6HLO_A_GBQA1501_0 (SUBSTANCE-P RECEPTOR,GLGA GLYCOGEN SYNTHASE,SUBSTANCE-P RECEPTOR)	1v0f	ENDO-ALPHA-SIALIDASE (Enterobacteria phage K1F)	5 / 12	PRO A 548 ILE A 571 TYR A 541 HIS A 542 THR A 524	PRO A 548 ( 1.1A) ILE A 571 ( 0.7A) TYR A 541 ( 1.3A) HIS A 542 ( 1.0A) THR A 524 ( 0.9A)	1.29A	6hloA-1v0fA: 0.0	6hloA-1v0fA: 21.46

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1FDU_A_ESTA351_1","17-BETA-HYDROXYSTEROID DEHYDROGENASE","1v0f","ENDO-ALPHA-SIALIDASE","Enterobacteria phage K1F",5,"VAL A 551;GLY A 552;LEU A 593;LEU A 620;SER A 619","VAL A 551 ( 0.6A);GLY A 552 ( 0.0A);LEU A 593 ( 0.5A);LEU A 620 ( 0.6A);SER A 619 ( 0.0A)","1.04A","1fduA-1v0fA:undetectable","1fduA-1v0fA:19.05"],["1KQB_D_BEZD523_0","OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE","1v0f","ENDO-ALPHA-SIALIDASE","Enterobacteria phage K1F",4,"PHE A 718;GLU A 721;GLY A 720;SER A 700","PHE A 718 ( 1.3A);GLU A 721 ( 0.6A);GLY A 720 ( 0.0A);SER A 700 ( 0.0A)","1.16A","1kqbC-1v0fA:undetectable;1kqbD-1v0fA:undetectable","1kqbC-1v0fA:14.61;1kqbD-1v0fA:14.61"],["1MAA_B_DMEB996_1","ACETYLCHOLINESTERASE;ACETYLCHOLINESTERASE","1v0f","ENDO-ALPHA-SIALIDASE","Enterobacteria phage K1F",4,"GLU A 309;ILE A 714;TYR A 713;GLY A 755","GLU A 309 ( 0.6A);ILE A 714 ( 0.7A);TYR A 713 ( 1.3A);GLY A 755 ( 0.0A)","1.05A","1maaB-1v0fA:undetectable;1maaD-1v0fA:undetectable","1maaB-1v0fA:22.78;1maaD-1v0fA:22.78"],["1W5U_B_DVAB8_0","GRAMICIDIN D","1v0f","ENDO-ALPHA-SIALIDASE","Enterobacteria phage K1F",3,"VAL A 704;VAL A 702;TRP A 328","VAL A 704 ( 0.6A);VAL A 702 ( 0.5A);TRP A 328 ( 0.5A)","0.95A","1w5uA-1v0fA:undetectable;1w5uB-1v0fA:undetectable","1w5uA-1v0fA:3.41;1w5uB-1v0fA:3.41"],["2A3C_A_PNXA1435_1","CHITINASE","1v0f","ENDO-ALPHA-SIALIDASE","Enterobacteria phage K1F",4,"TYR A 716;GLY A 597;SER A 605;ARG A 596","TYR A 716 ( 1.3A);GLY A 597 ( 0.0A);SER A 605 ( 0.0A);ARG A 596 ( 0.6A)","1.24A","2a3cA-1v0fA:undetectable","2a3cA-1v0fA:21.69"],["2A3C_B_PNXB2434_1","CHITINASE","1v0f","ENDO-ALPHA-SIALIDASE","Enterobacteria phage K1F",4,"TYR A 716;GLY A 597;SER A 605;ARG A 596","TYR A 716 ( 1.3A);GLY A 597 ( 0.0A);SER A 605 ( 0.0A);ARG A 596 ( 0.6A)","1.22A","2a3cB-1v0fA:undetectable","2a3cB-1v0fA:21.69"],["2IJ7_D_TPFD2473_1","CYTOCHROME P450 121","1v0f","ENDO-ALPHA-SIALIDASE","Enterobacteria phage K1F",5,"THR A 465;VAL A 464;ASN A 495;THR A 434;ALA A 436","THR A 465 ( 0.9A);VAL A 464 ( 0.6A);ASN A 495 ( 0.6A);THR A 434 ( 0.9A);ALA A 436 ( 0.0A)","1.32A","2ij7D-1v0fA:0.0","2ij7D-1v0fA:20.06"],["2IZQ_C_DVAC8_0","GRAMICIDIN D","1v0f","ENDO-ALPHA-SIALIDASE","Enterobacteria phage K1F",3,"VAL A 702;TRP A 328;VAL A 704","VAL A 702 ( 0.5A);TRP A 328 ( 0.5A);VAL A 704 ( 0.6A)","0.98A","2izqC-1v0fA:undetectable;2izqD-1v0fA:undetectable","2izqC-1v0fA:3.41;2izqD-1v0fA:3.41"],["2VOU_B_ACTB1391_0","2,6-DIHYDROXYPYRIDINE HYDROXYLASE","1v0f","ENDO-ALPHA-SIALIDASE","Enterobacteria phage K1F",3,"PRO A 632;GLY A 705;TYR A 716","PRO A 632 ( 1.1A);GLY A 705 ( 0.0A);TYR A 716 ( 1.3A)","0.65A","2vouB-1v0fA:undetectable","2vouB-1v0fA:22.22"],["2VOU_C_ACTC1391_0","2,6-DIHYDROXYPYRIDINE HYDROXYLASE","1v0f","ENDO-ALPHA-SIALIDASE","Enterobacteria phage K1F",3,"PRO A 632;GLY A 705;TYR A 716","PRO A 632 ( 1.1A);GLY A 705 ( 0.0A);TYR A 716 ( 1.3A)","0.66A","2vouC-1v0fA:undetectable","2vouC-1v0fA:22.22"],["2XRZ_B_ACTB1463_0","DEOXYRIBODIPYRIMIDINE PHOTOLYASE","1v0f","ENDO-ALPHA-SIALIDASE","Enterobacteria phage K1F",4,"VAL A 464;ILE A 433;ALA A 442;GLY A 466","VAL A 464 ( 0.6A);ILE A 433 ( 0.7A);ALA A 442 ( 0.0A);GLY A 466 ( 0.0A)","0.75A","2xrzB-1v0fA:undetectable","2xrzB-1v0fA:20.93"],["3AI8_B_HNQB255_1","CATHEPSIN B","1v0f","ENDO-ALPHA-SIALIDASE","Enterobacteria phage K1F",4,"GLN A 330;GLY A 705;HIS A 350;TRP A 328","GLN A 330 ( 0.6A);GLY A 705 ( 0.0A);HIS A 350 ( 1.0A);TRP A 328 ( 0.5A)","1.46A","3ai8B-1v0fA:undetectable","3ai8B-1v0fA:17.52"],["4KHP_A_PARA1606_1","16S RIBOSOMAL RNA;30S RIBOSOMAL PROTEIN S9;30S RIBOSOMAL PROTEIN S10","1v0f","ENDO-ALPHA-SIALIDASE","Enterobacteria phage K1F",3,"TYR A 382;ARG A 354;SER A 353","TYR A 382 ( 1.3A);ARG A 354 ( 0.6A);SER A 353 ( 0.0A)","1.11A","4khpI-1v0fA:undetectable;4khpJ-1v0fA:undetectable","4khpI-1v0fA:11.48;4khpJ-1v0fA:9.83"],["4KOS_A_4KOA201_1","UNCHARACTERIZED PROTEIN","1v0f","ENDO-ALPHA-SIALIDASE","Enterobacteria phage K1F",5,"PRO A 372;TYR A 324;GLY A 346;ASN A 326;MET A 345","PRO A 372 ( 1.1A);TYR A 324 ( 1.3A);GLY A 346 ( 0.0A);ASN A 326 ( 0.6A);MET A 345 ( 0.0A)","1.34A","4kosA-1v0fA:undetectable","4kosA-1v0fA:12.37"],["4KOV_A_KOVA204_1","UNCHARACTERIZED PROTEIN","1v0f","ENDO-ALPHA-SIALIDASE","Enterobacteria phage K1F",5,"PRO A 372;TYR A 324;GLY A 346;ASN A 326;MET A 345","PRO A 372 ( 1.1A);TYR A 324 ( 1.3A);GLY A 346 ( 0.0A);ASN A 326 ( 0.6A);MET A 345 ( 0.0A)","1.36A","4kovA-1v0fA:undetectable","4kovA-1v0fA:12.37"],["4KOW_A_CFXA204_1","UNCHARACTERIZED PROTEIN","1v0f","ENDO-ALPHA-SIALIDASE","Enterobacteria phage K1F",5,"PRO A 372;TYR A 324;GLY A 346;ASN A 326;MET A 345","PRO A 372 ( 1.1A);TYR A 324 ( 1.3A);GLY A 346 ( 0.0A);ASN A 326 ( 0.6A);MET A 345 ( 0.0A)","1.34A","4kowA-1v0fA:0.0","4kowA-1v0fA:12.37"],["4KOX_A_CLSA205_1","UNCHARACTERIZED PROTEIN","1v0f","ENDO-ALPHA-SIALIDASE","Enterobacteria phage K1F",5,"PRO A 372;TYR A 324;GLY A 346;ASN A 326;MET A 345","PRO A 372 ( 1.1A);TYR A 324 ( 1.3A);GLY A 346 ( 0.0A);ASN A 326 ( 0.6A);MET A 345 ( 0.0A)","1.38A","4koxA-1v0fA:0.0","4koxA-1v0fA:12.37"],["4KOY_A_CSCA214_1","UNCHARACTERIZED PROTEIN","1v0f","ENDO-ALPHA-SIALIDASE","Enterobacteria phage K1F",5,"PRO A 372;TYR A 324;GLY A 346;ASN A 326;MET A 345","PRO A 372 ( 1.1A);TYR A 324 ( 1.3A);GLY A 346 ( 0.0A);ASN A 326 ( 0.6A);MET A 345 ( 0.0A)","1.37A","4koyA-1v0fA:undetectable","4koyA-1v0fA:12.37"],["4X5I_A_FOLA201_1","DIHYDROFOLATE REDUCTASE","1v0f","ENDO-ALPHA-SIALIDASE","Enterobacteria phage K1F",3,"ASP A 731;ARG A 349;ARG A 354","ASP A 731 ( 0.6A);ARG A 349 ( 0.6A);ARG A 354 ( 0.6A)","0.96A","4x5iA-1v0fA:0.0","4x5iA-1v0fA:15.33"],["4YMG_B_SAMB1001_1","PUTATIVE SAM-DEPENDENT O-METHYLTRANFERASE","1v0f","ENDO-ALPHA-SIALIDASE","Enterobacteria phage K1F",3,"SER A 605;GLU A 651;GLU A 721","SER A 605 ( 0.0A);GLU A 651 ( 0.6A);GLU A 721 ( 0.6A)","0.87A","4ymgB-1v0fA:undetectable","4ymgB-1v0fA:17.42"],["5CZY_A_SAMA603_0","LEGIONELLA EFFECTOR LEGAS4","1v0f","ENDO-ALPHA-SIALIDASE","Enterobacteria phage K1F",5,"LEU A 640;ARG A 672;TYR A 670;TYR A 592;LEU A 607","LEU A 640 ( 0.5A);ARG A 672 ( 0.6A);TYR A 670 ( 1.3A);TYR A 592 ( 1.3A);LEU A 607 ( 0.5A)","1.33A","5czyA-1v0fA:undetectable","5czyA-1v0fA:20.58"],["5ECO_A_LEUA602_0","JASMONIC ACID-AMIDO SYNTHETASE JAR1","1v0f","ENDO-ALPHA-SIALIDASE","Enterobacteria phage K1F",4,"THR A 483;ALA A 474;THR A 475;VAL A 453","THR A 483 ( 0.9A);ALA A 474 ( 0.0A);THR A 475 ( 0.9A);VAL A 453 ( 0.6A)","0.74A","5ecoA-1v0fA:undetectable","5ecoA-1v0fA:23.52"],["5N8J_E_DVAE7_0","GLY-DTY-GLY-DLE-DAL-DSG-DVA-DAS-DGL-DSN-DSN-GLY;STREPTAVIDIN","1v0f","ENDO-ALPHA-SIALIDASE","Enterobacteria phage K1F",3,"TYR A 592;SER A 610;TRP A 678","TYR A 592 ( 1.3A);SER A 610 ( 0.0A);TRP A 678 ( 0.5A)","0.98A","5n8jB-1v0fA:undetectable","5n8jB-1v0fA:13.96"],["5N8J_O_DVAO7_0","GLY-DTY-GLY-DLE-DAL-DSG-DVA-DAS-DGL-DSN-DSN-GLY;STREPTAVIDIN","1v0f","ENDO-ALPHA-SIALIDASE","Enterobacteria phage K1F",3,"TYR A 592;SER A 610;TRP A 678","TYR A 592 ( 1.3A);SER A 610 ( 0.0A);TRP A 678 ( 0.5A)","0.93A","5n8jA-1v0fA:undetectable","5n8jA-1v0fA:13.96"],["5N8J_P_DVAP5_0","GLY-DTY-GLY-DLE-DAL-DSG-DVA-DAS-DGL-DSN-DSN-GLY;STREPTAVIDIN","1v0f","ENDO-ALPHA-SIALIDASE","Enterobacteria phage K1F",3,"TYR A 592;SER A 610;TRP A 678","TYR A 592 ( 1.3A);SER A 610 ( 0.0A);TRP A 678 ( 0.5A)","0.90A","5n8jD-1v0fA:undetectable","5n8jD-1v0fA:13.96"],["6BRD_C_RFPC502_1","RIFAMPIN MONOOXYGENASE","1v0f","ENDO-ALPHA-SIALIDASE","Enterobacteria phage K1F",5,"VAL A 473;VAL A 457;GLY A 431;THR A 465;GLY A 466","VAL A 473 ( 0.6A);VAL A 457 ( 0.6A);GLY A 431 ( 0.0A);THR A 465 ( 0.9A);GLY A 466 ( 0.0A)","1.08A","6brdC-1v0fA:undetectable","6brdC-1v0fA:7.96"],["6DWJ_B_GLYB710_0","DEOXYNUCLEOSIDE TRIPHOSPHATE TRIPHOSPHOHYDROLASE SAMHD1","1v0f","ENDO-ALPHA-SIALIDASE","Enterobacteria phage K1F",4,"ARG A 784;GLY A 782;ASN A 781;ASP A 779","ARG A 784 ( 0.6A);GLY A 782 ( 0.0A);ASN A 781 ( 0.6A);ASP A 779 ( 0.6A)","1.38A","6dwjB-1v0fA:undetectable;6dwjD-1v0fA:undetectable","6dwjB-1v0fA:21.34;6dwjD-1v0fA:21.34"],["6GH9_A_MIXA1003_0","UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 15","1v0f","ENDO-ALPHA-SIALIDASE","Enterobacteria phage K1F",4,"ASN A 732;TYR A 325;GLY A 346;HIS A 743","ASN A 732 ( 0.6A);TYR A 325 ( 1.3A);GLY A 346 ( 0.0A);HIS A 743 ( 1.0A)","1.29A","6gh9A-1v0fA:undetectable","6gh9A-1v0fA:10.02"],["6HD4_A_STIA604_1","TYROSINE-PROTEIN KINASE ABL1","1v0f","ENDO-ALPHA-SIALIDASE","Enterobacteria phage K1F",4,"TYR A 278;VAL A 267;PHE A 311;GLY A 275","TYR A 278 ( 1.3A);VAL A 267 ( 0.5A);PHE A 311 ( 1.3A);GLY A 275 ( 0.0A)","1.32A","6hd4A-1v0fA:undetectable","6hd4A-1v0fA:8.19"],["6HIS_B_TKTB508_0","5-HYDROXYTRYPTAMINE RECEPTOR 3A","1v0f","ENDO-ALPHA-SIALIDASE","Enterobacteria phage K1F",4,"ASP A 420;ARG A 398;ARG A 513;ASN A 534","ASP A 420 ( 0.6A);ARG A 398 ( 0.6A);ARG A 513 ( 0.6A);ASN A 534 ( 0.6A)","1.03A","6hisB-1v0fA:undetectable;6hisC-1v0fA:undetectable","6hisB-1v0fA:8.39;6hisC-1v0fA:8.39"],["6HIS_C_TKTC508_0","5-HYDROXYTRYPTAMINE RECEPTOR 3A","1v0f","ENDO-ALPHA-SIALIDASE","Enterobacteria phage K1F",4,"ASP A 420;ARG A 398;ARG A 513;ASN A 534","ASP A 420 ( 0.6A);ARG A 398 ( 0.6A);ARG A 513 ( 0.6A);ASN A 534 ( 0.6A)","1.01A","6hisC-1v0fA:undetectable;6hisD-1v0fA:undetectable","6hisC-1v0fA:8.39;6hisD-1v0fA:8.39"],["6HIS_E_TKTE501_0","5-HYDROXYTRYPTAMINE RECEPTOR 3A","1v0f","ENDO-ALPHA-SIALIDASE","Enterobacteria phage K1F",4,"ASN A 534;ASP A 420;ARG A 398;ARG A 513","ASN A 534 ( 0.6A);ASP A 420 ( 0.6A);ARG A 398 ( 0.6A);ARG A 513 ( 0.6A)","1.01A","6hisA-1v0fA:undetectable;6hisE-1v0fA:undetectable","6hisA-1v0fA:8.39;6hisE-1v0fA:8.39"],["6HLO_A_GBQA1501_0","SUBSTANCE-P RECEPTOR,GLGA GLYCOGEN SYNTHASE,SUBSTANCE-P RECEPTOR","1v0f","ENDO-ALPHA-SIALIDASE","Enterobacteria phage K1F",5,"PRO A 548;ILE A 571;TYR A 541;HIS A 542;THR A 524","PRO A 548 ( 1.1A);ILE A 571 ( 0.7A);TYR A 541 ( 1.3A);HIS A 542 ( 1.0A);THR A 524 ( 0.9A)","1.29A","6hloA-1v0fA:0.0","6hloA-1v0fA:21.46"]]